Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats.
Hiroki HayashiJiao SunYuka YanagidaShota YoshidaSatoshi BabaAkiko TenmaMasayoshi ToyouraSotaro KawabataTakako EharaRyoko AsakiMakoto SakaguchiHideki TomiokaMunehisa ShimamuraRyuichi MorishitaHiromi RakugiTetsuya TomitaHironori NakagamiPublished in: RMD open (2023)
IL17A peptide-based vaccine may be a therapeutic option for SpA treatment.